Reid Merryman, Md
Clinical trials sponsored by Reid Merryman, Md, explained in plain language.
-
New hope for lymphoma patients: drug duo tested as first-line therapy
Disease control Recruiting nowThis study tests a combination of two drugs, epcoritamab and rituximab, as the first treatment for people with follicular lymphoma, a slow-growing blood cancer. About 100 adults who have not had prior lymphoma therapy will receive the drugs to see how well they shrink tumors and …
Phase: PHASE2 • Sponsor: Reid Merryman, MD • Aim: Disease control
Last updated May 26, 2026 04:48 UTC
-
New drug cocktail aims to beat back lymphoma in relapsed patients
Disease control Recruiting nowThis study tests a combination of three drugs—epcoritamab, zanubrutinib, and rituximab—in people with follicular lymphoma or marginal zone lymphoma that has come back or not responded to prior treatment. The goal is to see how well the combo works at shrinking tumors and to check…
Phase: PHASE2 • Sponsor: Reid Merryman, MD • Aim: Disease control
Last updated May 13, 2026 16:01 UTC